Breaking News Instant updates and real-time market news.

2022-05-05 16:59:40 PRQR ProQR Therapeutics / + 16:59 05/05/22 05/05 16:59 05/05/22 16:59	ProQR Therapeutics reports Q1 EPS (20c), consensus (25c) The company said it has cash runway into 2025.

2022-05-05 16:59:40

PRQR

ProQR Therapeutics

/ +

16:59

05/05/22

05/05

16:59

05/05/22

16:59

ProQR Therapeutics reports Q1 EPS (20c), consensus (25c)

The company said it has cash runway into 2025.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Alignment Healthcare appoints Randall Fitzpatrick as SVP, product » 08:13 07/05/22 07/05 08:13 07/05/22 08:13 ALHC Alignment Healthcare $11.58 / +0.19 (+1.67%) Alignment Healthcare… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate ALHC Alignment Healthcare $11.58 / +0.19 (+1.67%) 06/29/22 Alignment Healthcare to expand to Florida, Texas 04/06/22 Alignment Healthcare expands roles for two executive team members 03/30/22 Alignment Healthcare celebrates one year as public company 01/10/22 Alignment Healthcare announces preliminary inpatient utilization for Q4 ALHC Alignment Healthcare $11.58 / +0.19 (+1.67%) 05/26/22 BofA Alignment Healthcare upgraded to Buy from Neutral at BofA 03/04/22 Cowen Alignment Healthcare price target lowered to $11 from $24 at Cowen 03/04/22 Barclays Alignment Healthcare price target lowered to $14 from $28 at Barclays 02/24/22 Piper Sandler Alignment Healthcare price target lowered to $15 from $25 at Piper Sandler ALHC Alignment Healthcare $11.58 / +0.19 (+1.67%) 03/03/22 Alignment Healthcare reports Q4 EPS (27c), consensus (30c) 19 Nov
Hot Stocks	PowerFleet selected as preferred partner by AXA Seguros » 08:12 07/05/22 07/05 08:12 07/05/22 08:12 PWFL PowerFleet $2.15 / +0.01 (+0.47%) PowerFleet announced it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PWFL PowerFleet $2.15 / +0.01 (+0.47%) 04/25/22 PowerFleet appoints Maley as CRO, US General Manager 04/11/22 PowerFleet appoints Zeitunian as Chief Technology Officer 04/07/22 PowerFleet CFO Ned Mavrommatis to depart 02/17/22 Kautex expands adoption of PowerFleet telematics solution PWFL PowerFleet $2.15 / +0.01 (+0.47%) 05/11/22 Canaccord PowerFleet price target lowered to $6 from $9 at Canaccord 05/10/22 Barrington Barrington downgrades PowerFleet on 'long recovery' in profitability 05/10/22 Barrington PowerFleet downgraded to Market Perform from Outperform at Barrington 03/10/22 Lake Street PowerFleet price target lowered to $7 from $9 at Lake Street PWFL PowerFleet $2.15 / +0.01 (+0.47%) 05/10/22 PowerFleet reports Q1 adjusted EPS (6c), consensus (10c) 03/09/22 PowerFleet reports Q4 adjusted EPS 5c, consensus (9c) 07/19/22 PowerFleet Inc
Hot Stocks	Reservoir Media added to Russell 2000 Index » 08:12 07/05/22 07/05 08:12 07/05/22 08:12 RSVR Reservoir Media $6.28 / -0.25 (-3.83%) Reservoir Media announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options RSVR Reservoir Media $6.28 / -0.25 (-3.83%) 05/10/22 Reservoir Media announces deal with Mohamed Ramadan, purchase of 100COPIES 03/29/22 Reservoir Media announces deal for catalog of Larry Kusik 03/22/22 Reservoir Media acquires rights to the catalog of composer Henry Jackman 03/15/22 Reservoir Media announces publishing deal with Killer Mike RSVR Reservoir Media $6.28 / -0.25 (-3.83%) 08/23/21 Craig-Hallum Craig-Hallum bullish on Reservoir Media, initiates with a Buy 08/23/21 Craig-Hallum Reservoir Media initiated with a Buy at Craig-Hallum 08/23/21 Roth Capital Reservoir Media initiated with a Buy at Roth Capital RSVR Reservoir Media $6.28 / -0.25 (-3.83%) 06/21/22 Reservoir Media sees 2023 revenue $116M-$121M, consensus $118.93M 06/21/22 Reservoir Media reports Q4 EPS 14c, consensus 9c 02/08/22 Reservoir Media raises FY22 revenue view to $103M-$105M from $100M-$104M 02/08/22 Reservoir Media reports Q3 EPS 3c, three estimates 3c RSVR Reservoir Media $6.28 / -0.25 (-3.83%) 06/21/22 What You Missed On Wall Street On Tuesday 06/21/22 What You Missed On Wall Street This Morning 06/21/22 Fly Intel: Pre-market Movers 03/14/22 Fly Insider: Ball Corp, Datadog among week's notable insider trades RSVR Reservoir Media $6.28 / -0.25 (-3.83%) 06/23/22 Fourteen new option listings and one option delisting on June 23rd
Hot Stocks	Vertex Pharmaceuticals announces FDA lifts clinical hold on VX-880 trial » 08:12 07/05/22 07/05 08:12 07/05/22 08:12 VRTX Vertex Pharmaceuticals $287.06 / +5.695 (+2.02%) Vertex Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options VRTX Vertex Pharmaceuticals $287.06 / +5.695 (+2.02%) 07/01/22 Teva appoints Eric Hughes as CMO 06/12/22 Vertex, Crispr Therapeutics present new data on exa-cel 06/10/22 Vertex Pharmaceuticals to present data on treatment with CFTR modulators 06/08/22 Vertex Pharmaceuticals announces VX-147 granted BTD by US, PRIME by EMA VRTX Vertex Pharmaceuticals $287.06 / +5.695 (+2.02%) 06/13/22 Argus Vertex Pharmaceuticals price target raised to $280 from $275 at Argus 06/13/22 Cowen Vertex Pharmaceuticals price target raised to $310 from $305 at Cowen 06/13/22 Stifel Crispr Therapeutics price target raised to $57 from $52 at Stifel 06/01/22 Maxim Maxim upgrades Vertex Pharmaceuticals to Buy as company expands beyond CF VRTX Vertex Pharmaceuticals $287.06 / +5.695 (+2.02%) 05/05/22 Vertex Pharmaceuticals reports Q1 adjusted EPS $3.52, consensus $3.49 05/05/22 Notable companies reporting after market close 01/26/22 Vertex Pharmaceuticals reports Q4 EPS $3.37, consensus $3.29 01/26/22 Notable companies reporting after market close VRTX Vertex Pharmaceuticals $287.06 / +5.695 (+2.02%) 01/08/22 Biotech due to bounce back, Vertex stands out, Barron's says VRTX Vertex Pharmaceuticals $287.06 / +5.695 (+2.02%) 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning 06/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/23/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations VRTX Vertex Pharmaceuticals $287.06 / +5.695 (+2.02%) 01/10/22 Early notable gainers among liquid option names on January 10th
Recommendations	Oppenheimer remains bullish on Tesla following Q2 deliveries » 08:11 07/05/22 07/05 08:11 07/05/22 08:11 TSLA Tesla $681.64 / +8.33 (+1.24%) Oppenheimer analyst Colin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TSLA Tesla $681.64 / +8.33 (+1.24%) 07/04/22 Fly Intel: Top five weekend stock stories 07/02/22 Tesla reports Q2 deliveries of 254,695, says June highest production month 06/29/22 Tesla exec sells $2.62M in common stock 06/26/22 Fly Intel: Top five weekend stock stories TSLA Tesla $681.64 / +8.33 (+1.24%) 07:26 Today Wedbush Wedbush sees focus on 2H trajectory after Tesla's 'ugly' delivery numbers 06:53 Today Deutsche Bank Tesla reported 'respectable' Q2 deliveries, says Deutsche Bank 06:03 Today JPMorgan Tesla price target lowered to $385 from $395 at JPMorgan 07/04/22 Bernstein Tesla's FY22 goal of 1.5M deliveries 'potentially a stretch,' says Bernstein TSLA Tesla $681.64 / +8.33 (+1.24%) 04/20/22 Tesla reports Q1 EPS $3.22, consensus $2.26 04/20/22 Notable companies reporting after market close 01/26/22 Tesla reports Q4 non-GAAP EPS $2.54, consensus $2.26 01/26/22 Notable companies reporting after market close TSLA Tesla $681.64 / +8.33 (+1.24%) 05:43 Today Tesla supplier Ganfeng Lithium probed for insider trading in China, FT reports 07/04/22 German agency says 59k Tesla vehicles have software glitch, Reuters reports 07/01/22 SOC Investment requests SEC investigate Tesla over board plans, CNBC says 07/01/22 Tesla faces new lawsuit over racial abuse, Reuters reports TSLA Tesla $681.64 / +8.33 (+1.24%) 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning 06/29/22 What You Missed On Wall Street On Wednesday 06/29/22 #SocialStocks: Pinterest taps former Google executive as CEO 07/20/22 Tesla - TSLA 08/04/22 Tesla, Inc. TSLA Tesla $681.64 / +8.33 (+1.24%) 07/01/22 Notable open interest changes for July 1st 06/28/22 Notable open interest changes for June 28th 06/27/22 Notable open interest changes for June 27th 06/23/22 Notable open interest changes for June 23rd
Hot Stocks	Agilent announces FDA approval of Agilent TRS100 content uniformity » 08:11 07/05/22 07/05 08:11 07/05/22 08:11 A Agilent $119.16 / +0.775 (+0.65%) , TEVA Teva $7.88 / +0.355 (+4.72%) Agilent (A) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options A TEVA A Agilent $119.16 / +0.775 (+0.65%) 05/27/22 Agilent, APC announce liquid chromatography collaboration agreement 05/10/22 Agilent reports expanded CE-IVD mark in Europe for companion diagnostic 04/05/22 Agilent expands CE-IVD marking in EU for PD-L1 IHC 28-8 pharmDx 02/28/22 Singular Genomics partners with Agilent for NGS Target Enrichment products TEVA Teva $7.88 / +0.355 (+4.72%) 07:04 Today Lyra Therapeutics appoints Nieman as Chief Medical Officer 07/01/22 Teva appoints Eric Hughes as CMO 06/24/22 Teva says interim results from PEARL study of Ajovy 'promising' 06/09/22 Teva announces settlement with Aurobindo resolving AUSTEDO patent dispute A TEVA A Agilent $119.16 / +0.775 (+0.65%) 06/03/22 Cowen Agilent premium valuation remains warranted, says Cowen 06/02/22 KeyBanc Agilent price target lowered to $155 from $195 at KeyBanc 05/25/22 Baird Agilent price target raised to $161 from $155 at Baird 05/16/22 Citi Citi opens 'positive catalyst watch' on Agilent into earnings TEVA Teva $7.88 / +0.355 (+4.72%) 06/13/22 UBS Teva initiated with a Neutral at UBS 06/13/22 UBS Teva initiated with a Neutral at UBS 05/17/22 BofA Teva upgraded to Neutral at BofA on potential opioid deal upside 05/17/22 BofA Teva upgraded to Neutral from Underperform at BofA A TEVA A Agilent $119.16 / +0.775 (+0.65%) 05/24/22 Agilent raises FY22 EPS view to $4.86-$4.93, consensus $4.60 05/24/22 Agilent sees Q3 EPS $1.20-$1.22, consensus $1.12 05/24/22 Agilent reports Q2 EPS $1.13, consensus $1.06 02/22/22 Agilent raises FY22 EPS view to $4.80-$4.90, consensus $4.27 TEVA Teva $7.88 / +0.355 (+4.72%) 05/03/22 Teva backs FY22 adjusted EPS view $2.40-$2.60, consensus $2.51 05/03/22 Teva reports Q1 EPS 55c, consensus 55c 02/09/22 Teva sees FY22 EPS $2.40-$2.60, consensus $2.64 02/09/22 Teva reports Q4 EPS 77c, consensus 73c TEVA TEVA Teva $7.88 / +0.355 (+4.72%) 05/10/22 Teva, Allergan offering over $5B to settle opioid suits, Bloomberg says 05/10/22 Teva, Allergan offering over $5B to settle opioid suits, Bloomberg says A TEVA A Agilent $119.16 / +0.775 (+0.65%) 06/13/22 Fly Insider: Tela Bio, Airbnb among week's notable insider trades 05/24/22 Fly Intel: After-Hours Movers 03/28/22 Fly Insider: GameStop, Agilent among this week's notable insider trades TEVA Teva $7.88 / +0.355 (+4.72%) 05/25/22 What You Missed On Wall Street On Wednesday 05/25/22 What You Missed On Wall Street This Morning 05/10/22 What You Missed On Wall Street On Tuesday 05/04/22 What You Missed On Wall Street On Wednesday 07/12/22 SEMICon West 2022 07/27/22 Teva - TEVA A TEVA A Agilent $119.16 / +0.775 (+0.65%) 05/24/22 Agilent options imply 4.7% move in share price post-earnings TEVA Teva $7.88 / +0.355 (+4.72%) 06/30/22 Teva put volume heavy and directionally bearish 06/28/22 Teva call volume above normal and directionally bullish 06/27/22 Teva call volume above normal and directionally bullish 05/24/22 Teva put volume heavy and directionally bearish
Downgrade	PerkinElmer downgraded to In Line at Evercore on valuation and macro sensitivity » 08:11 07/05/22 07/05 08:11 07/05/22 08:11 PKI PerkinElmer $144.07 / +2.05 (+1.44%) Evercore ISI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Options PKI PerkinElmer $144.07 / +2.05 (+1.44%) 06:41 Today Evercore ISI PerkinElmer downgraded to In Line from Outperform at Evercore ISI 05/17/22 Barclays PerkinElmer initiated with an Underweight at Barclays 05/04/22 Baird PerkinElmer price target lowered to $198 from $216 at Baird 05/04/22 Citi PerkinElmer price target lowered to $170 from $185 at Citi PKI PerkinElmer $144.07 / +2.05 (+1.44%) 02/01/22 PerkinElmer sees FY22 adjusted EPS $6.80-$7.00, consensus $6.60 02/01/22 PerkinElmer sees Q1 adjusted EPS $2.05-$2.10, consensus $1.51 02/01/22 PerkinElmer reports Q4 adjusted EPS $2.56, consensus $2.19 01/11/22 PerkinElmer raises FY21 revenue view to $5B from $4.9B, consensus $4.92B PKI PerkinElmer $144.07 / +2.05 (+1.44%) 02/01/22 PerkinElmer options imply 4.4% move in share price post-earnings
Hot Stocks	Xperi acquires Vewd Software Holdings for $109M » 08:11 07/05/22 07/05 08:11 07/05/22 08:11 XPER Xperi $14.32 / -0.03 (-0.21%) Xperi Holding announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly XPER Xperi $14.32 / -0.03 (-0.21%) 06/13/22 Xperi's Adeia receives decision in Videotron litigation 05/12/22 SkyWater in license pact with Xperi for hybrid bonding technology 04/05/22 TiVo Stream 4K to fully integrate with YouTube TV 02/23/22 Xperi, Micron enter license agreement for Hybrid Bonding XPER Xperi $14.32 / -0.03 (-0.21%) 06/15/22 BWS Financial Xperi adverse ruling not material to underlying business, says BWS Financial 01/03/22 BWS Financial Xperi upgraded to Top Pick from Buy at BWS Financial 08/19/21 Maxim Xperi initiated with a Buy at Maxim XPER Xperi $14.32 / -0.03 (-0.21%) 06/23/22 Xperi ups FY22 revenue view to $920M-$960M from $910M-$950M, consensus $927.75M 05/09/22 Xperi backs FY22 revenue $910M-$950M, consensus $923.13M 05/09/22 Xperi reports Q1 adjusted EPS 92c, consensus 63c 02/23/22 Xperi sees FY22 revenue $910M-$950M, consensus $906.24M XPER Xperi $14.32 / -0.03 (-0.21%) 06/23/22 What You Missed On Wall Street This Morning 06/13/22 Fly Intel: After-Hours Movers
Hot Stocks	Osisko Development announces agreement between WLFN and BGM » 08:10 07/05/22 07/05 08:10 07/05/22 08:10 ODV Osisko Development $4.86 / +0.04 (+0.83%) Osisko Development… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research ODV Osisko Development $4.86 / +0.04 (+0.83%) 07/01/22 Osisko Development appoints Laurence Farmer as general counsel 07/01/22 Osisko Development announces annual grant of stock options 06/30/22 Osisko announces initial pit resource estimation for San Antonio Property 06/28/22 Osisko Development announces Tintic Project update ODV Osisko Development $4.86 / +0.04 (+0.83%) 06/06/22 National Bank Osisko Development price target lowered to C$15 from C$27 at National Bank 05/27/22 Desjardins Osisko Development downgraded to Hold from Buy at Desjardins
Hot Stocks	Shell, AMG Recycling, Aramco enter agreement for supercenter complex » 08:10 07/05/22 07/05 08:10 07/05/22 08:10 SHEL Shell $51.89 / -0.395 (-0.76%) Shell & AMG Recycling… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SHEL Shell $51.89 / -0.395 (-0.76%) 06/29/22 Equinor sells 51% interest in North Platte project to Shell 06/27/22 Wolf Capital issues open letter on Shell's offer for Shell Midstream Partners 06/22/22 President Biden calls on Congress to suspend federal gas tax 06/12/22 Fly Intel: Top five weekend stock stories SHEL Shell $51.89 / -0.395 (-0.76%) 06/09/22 Credit Suisse Shell initiated with an Outperform at Credit Suisse 05/11/22 Morgan Stanley Shell price target raised to 2,860 GBp from 2,570 GBp at Morgan Stanley 05/06/22 UBS Shell price target raised to 2,550 GBp from 2,450 GBp at UBS 04/19/22 JPMorgan Shell price target raised to 2,850 GBp from 2,700 GBp at JPMorgan SHEL Shell $51.89 / -0.395 (-0.76%) 05/05/22 Shell reports Q1 adjusted EPS $1.20 vs. 42c last year SHEL Shell $51.89 / -0.395 (-0.76%) 06/15/22 Biden calls on oil refiners to boost supply of gas, diesel, CNBC reports 06/14/22 Finance chair to propose surtax on excessive oil company profits, Bloomberg says 06/11/22 Sunrun, Shell among energy stocks to consider, Barron's says 06/10/22 Biden accuses U.S. oil industry of capitalizing on supply shortage, Reuters says SHEL Shell $51.89 / -0.395 (-0.76%) 06/15/22 What You Missed On Wall Street On Wednesday 06/09/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/08/22 What You Missed On Wall Street On Wednesday 05/31/22 What You Missed On Wall Street On Tuesday SHEL Shell $51.89 / -0.395 (-0.76%) 06/29/22 Shell PLC put volume heavy and directionally bearish 06/16/22 Shell PLC put volume heavy and directionally bearish 06/13/22 Shell PLC call volume above normal and directionally bullish 03/07/22 Shell PLC (ADR) call volume above normal and directionally bullish

Hot Stocks	FinTech Acquisition Corp. V, eToro Group terminate merger agreement » 08:09 07/05/22 07/05 08:09 07/05/22 08:09 FTCV FinTech Acquisition Corp. V $9.86 / +0.005 (+0.05%) FinTech Acquisition Corp.… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Periodicals Options FTCV FinTech Acquisition Corp. V $9.86 / +0.005 (+0.05%) 09/20/21 Compass Point FinTech Acquisition initiated with Neutral ahead of deal at Compass Point 09/20/21 Compass Point FinTech Acquisition Corp. V initiated with a Neutral at Compass Point FTCV FinTech Acquisition Corp. V $9.86 / +0.005 (+0.05%) 07/01/22 FinTech Acquisition V, eToro to scrap SPAC merger plan, The Information says FTCV FinTech Acquisition Corp. V $9.86 / +0.005 (+0.05%) 07/01/22 Unusually active option classes on open July 1st 04/21/22 Largest borrow rate increases among liquid names
Hot Stocks	Precigen enters agreement to divest non-healthcare subsidiary Trans Ova to URUS » 08:09 07/05/22 07/05 08:09 07/05/22 08:09 PGEN Precigen $1.41 / +0.07 (+5.24%) Precigen announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly PGEN Precigen $1.41 / +0.07 (+5.24%) 04/04/22 Precigen says FDA grants Fast Track designation for PRGN-3006 UltraCAR-T PGEN Precigen $1.41 / +0.07 (+5.24%) 05/09/22 Precigen reports Q1 EPS (10c), consensus (13c) 03/01/22 Precigen reports Q4 EPS (13c), consensus (14c) PGEN Precigen $1.41 / +0.07 (+5.24%) 02/05/22 Short Report: GitLab short position re-accelerates to record high
Hot Stocks	Genetic Technologies announces expansion of EasyDNA » 08:08 07/05/22 07/05 08:08 07/05/22 08:08 GENE Genetic Technologies $1.21 / +0.04 (+3.42%) Genetic Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News GENE Genetic Technologies $1.21 / +0.04 (+3.42%) 07/01/22 Genetic Technologies geneType Risk Assessment Test onboarding in 16 clinics 06/16/22 Genetic Technologies announces completion of Budget Impact Model 05/16/22 Genetic Technologies to acquire director to consumer ecommerce business 04/08/22 Genetic Technologies reports cash balance of A$11.43M
Hot Stocks	Applied UV says partner MedLine places 'large order' for S200 system » 08:08 07/05/22 07/05 08:08 07/05/22 08:08 AUVI Applied UV $2.18 / -0.05 (-2.24%) Applied UV, announces… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AUVI Applied UV $2.18 / -0.05 (-2.24%) 06/21/22 Applied UV subsidiary receives substantial order 06/09/22 Applied UV expands global distribution reach with M/S Novatek 05/17/22 Applied UV subsidiary included on multi-million dollar contract in Washington 05/13/22 Applied UV announces order for The Renaissance Cleveland Hotel AUVI Applied UV $2.18 / -0.05 (-2.24%) 06/27/22 Aegis Applied UV initiated with a Buy at Aegis 01/10/22 EF Hutton Applied UV initiated with a Buy at EF Hutton AUVI Applied UV $2.18 / -0.05 (-2.24%) 05/23/22 Applied UV reports Q1 EPS (16c), two estimates (16c)
Hot Stocks	Catalent chief commercial officer Karen Flynn retires, Jonathan Arnold succeeds » 08:08 07/05/22 07/05 08:08 07/05/22 08:08 CTLT Catalent $107.00 / -0.15 (-0.14%) Catalent announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options CTLT Catalent $107.00 / -0.15 (-0.14%) 05/03/22 Catalent rises 11.9% 04/25/22 Erytech Pharma sells U.S. manufacturing facility to Catalent for $44.5M 03/01/22 TFF Pharmaceuticals, Catalent announce development, manufacturing agreement 01/14/22 Catalent site inspection form posted by FDA CTLT Catalent $107.00 / -0.15 (-0.14%) 04/12/22 Deutsche Bank Catalent price target lowered to $110 from $129 at Deutsche Bank 02/02/22 Deutsche Bank Catalent price target lowered to $129 from $164 at Deutsche Bank 01/27/22 Barclays Catalent price target lowered to $130 from $160 at Barclays 12/21/21 Jefferies Catalent reaction to Novo Nordisk news 'seems slightly overdone,' says Jefferies CTLT Catalent $107.00 / -0.15 (-0.14%) 05/03/22 Catalent raises FY22 revenue to $4.800B-$4.900B from $4.740B-$4.860B 05/03/22 Catalent reports Q3 adjusted EPS $1.04, consensus 94c 02/01/22 Catalent raises FY22 revenue view to $4.74B-$4.86B from $4.62B-$4.82B 02/01/22 Catalent reports Q2 adjusted EPS 90c, consensus 83c CTLT Catalent $107.00 / -0.15 (-0.14%) 05/03/22 Early notable gainers among liquid option names on May 3rd 02/01/22 Early notable gainers among liquid option names on February 1st 01/10/22 Early notable gainers among liquid option names on January 10th
Recommendations	Agco price target lowered to $156 from $169 at Oppenheimer » 08:07 07/05/22 07/05 08:07 07/05/22 08:07 AGCO Agco $100.60 / +2.01 (+2.04%) Oppenheimer analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly AGCO Agco $100.60 / +2.01 (+2.04%) 06/15/22 AGCO's Gleaner brand marks 100th anniversary with model year 2023 06/15/22 Agco appoints Damon Audia to succeed Andy Beck as CFO effective July 1 05/16/22 Agco says operations running successfully following May 5 cyberattack 05/06/22 Agco announces ransomware attack AGCO Agco $100.60 / +2.01 (+2.04%) 06/23/22 Morgan Stanley Agco downgraded to Equal Weight from Overweight at Morgan Stanley 06/10/22 Deutsche Bank Agco price target lowered to $141 from $143 at Deutsche Bank 04/14/22 Deutsche Bank Agco price target raised to $143 from $141 at Deutsche Bank 03/28/22 JPMorgan JPMorgan ups Agco target, adds to Analyst Focus List AGCO Agco $100.60 / +2.01 (+2.04%) 05/03/22 Agco sees FY22 EPS $11.70- $11.90 , consensus $11.57 05/03/22 Agco reports Q1 EPS $2.39, consensus $1.90 02/08/22 Agco sees FY22 adjusted EPS $11.50, consensus $10.58 02/08/22 Agco reports Q4 adjusted EPS $3.08, consensus $1.77 AGCO Agco $100.60 / +2.01 (+2.04%) 03/22/22 Agriculture stocks see increased demand amid Ukraine turmoil, Bloomberg says 03/19/22 Brinker, Starbucks among stocks to buy among rising food costs, Barron's says AGCO Agco $100.60 / +2.01 (+2.04%) 06/23/22 Fly Intel: Pre-market Movers
Hot Stocks	Janel to launch cash tender offer to acquire 45% interest in Rubicon » 08:07 07/05/22 07/05 08:07 07/05/22 08:07 RBCN Rubicon $9.10 / -0.09 (-0.98%) Rubicon Technology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News RBCN Rubicon $9.10 / -0.09 (-0.98%) 05/10/22 Rubicon announces launch of RUBICONSelect
Initiation	Momentus initiated with an Underperform at Evercore ISI » 08:07 07/05/22 07/05 08:07 07/05/22 08:07 MNTS Momentus $2.16 / +0.01 (+0.47%) Evercore ISI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options MNTS Momentus $2.16 / +0.01 (+0.47%) 05/12/22 Momentus completes integration of Vigoride on SpaceX Falcon 9 05/05/22 Momentus completes all regulatory milestones for inaugural mission 04/29/22 Momentus receives FCC license for first flight 04/07/22 Momentus signs launch service agreements with SpaceX MNTS Momentus $2.16 / +0.01 (+0.47%) 05/23/22 Deutsche Bank Momentus named short-term buy idea at Deutsche Bank 05/11/22 Deutsche Bank Momentus price target lowered to $7 from $8 at Deutsche Bank 03/23/22 Deutsche Bank SpaceX decision 'clear positive' for Momentus, says Deutsche Bank 01/10/22 Deutsche Bank Momentus initiated with a Buy at Deutsche Bank MNTS Momentus $2.16 / +0.01 (+0.47%) 04/07/22 Fly Intel: Pre-market Movers MNTS Momentus $2.16 / +0.01 (+0.47%) 06/01/22 Largest borrow rate increases among liquid names 05/10/22 Momentus options imply 11.4% move in share price post-earnings 04/20/22 Largest borrow rate increases among liquid names 04/07/22 Unusually active option classes on open April 7th
Hot Stocks	Orchestra BioMed to list on Nasdaq via Health Sciences Acquisitions merger » 08:06 07/05/22 07/05 08:06 07/05/22 08:06 OBIO Orchestra BioMed / + , HSAQ Health Sciences Acquisitions $9.98 / +0.02 (+0.20%) , MDT Medtronic $91.33 / +1.685 (+1.88%) Orchestra BioMed and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MDT MDT Medtronic $91.33 / +1.685 (+1.88%) 06/27/22 Medtronic names Pfizer executive Lidia Fonseca as new director 06/13/22 IceCure Medical, Shanghai Medtronic, Turing Medical sign distribution agreement 05/26/22 Medtronic: Q1 EPS guidance includes FX headwind of about 5c 05/26/22 Medtronic: Procedure volumes in most markets reached pre-Covid levels by Q4E OBIO HSAQ MDT OBIO Orchestra BioMed / + HSAQ Health Sciences Acquisitions $9.98 / +0.02 (+0.20%) MDT Medtronic $91.33 / +1.685 (+1.88%) 06/01/22 Atlantic Equities Medtronic downgraded to Neutral from Overweight at Atlantic Equities 05/31/22 Raymond James Medtronic price target lowered to $109 from $116 at Raymond James 05/31/22 Truist Medtronic price target lowered to $111 from $121 at Truist 05/27/22 RBC Capital Medtronic price target lowered to $122 from $135 at RBC Capital MDT MDT Medtronic $91.33 / +1.685 (+1.88%) 05/26/22 Medtronic sees Q1 organic revenue down 4.5%-5.5%, consensus $8.14B 05/26/22 Medtronic sees Q1 EPS $1.10-$1.14, consensus $1.40 05/26/22 Medtronic sees FY23 EPS $5.53-$5.65, consensus $5.82 05/26/22 Medtronic reports Q4 EPS $1.52, consensus $1.56 MDT MDT Medtronic $91.33 / +1.685 (+1.88%) 02/05/22 Medtronic stock can gain 20% as COVID subsides, Barron's says MDT MDT Medtronic $91.33 / +1.685 (+1.88%) 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning 06/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/27/22 What You Missed On Wall Street This Morning 08/23/22 Medtronic - MDT MDT MDT Medtronic $91.33 / +1.685 (+1.88%) 07/01/22 Largest borrow rate increases among liquid names 04/27/22 Medtronic put volume heavy and directionally bearish 01/31/22 Medtronic put volume heavy and directionally bearish
Hot Stocks	IceCure Medical announces Glick will serve as a strategic advisor » 08:06 07/05/22 07/05 08:06 07/05/22 08:06 ICCM IceCure Medical $1.63 / -0.14 (-7.91%) IceCure Medical announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research ICCM IceCure Medical $1.63 / -0.14 (-7.91%) 06/13/22 IceCure Medical, Shanghai Medtronic, Turing Medical sign distribution agreement ICCM IceCure Medical $1.63 / -0.14 (-7.91%) 05/19/22 Alliance Global Partners IceCure price target lowered to $5.75 from $9.50 at Alliance Global 02/02/22 Brookline IceCure Medical initiated with a Buy at Brookline 01/14/22 Alliance Global Partners IceCure Medical price target lowered to $9.50 from $14.50 at Alliance Global 09/22/21 Alliance Global Partners IceCure Medical initiated with a Buy at Alliance Global Partners

Hot Stocks	Ayala announces interim results from Phase 2/3 clinical trial evaluating AL102 » 08:05 07/05/22 07/05 08:05 07/05/22 08:05 AYLA Ayala Pharmaceuticals $1.09 / +0.04 (+3.81%) Ayala Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AYLA Ayala Pharmaceuticals $1.09 / +0.04 (+3.81%) 06/06/22 Ayala Pharmaceuticals announces data on AL101 in ACC 03/08/22 Ayala, MD Anderson Cancer Center, ACC Research initiate AL101 study 02/23/22 Ayala Pharmaceuticals completes enrollment in Part A of RINGSIDE AYLA Ayala Pharmaceuticals $1.09 / +0.04 (+3.81%) 03/30/22 Maxim Ayala Pharmaceuticals price target lowered to $12 from $22 at Maxim 03/30/22 Oppenheimer Ayala Pharmaceuticals price target lowered to $16 from $25 at Oppenheimer 12/20/21 Maxim Ayala Pharmaceuticals initiated with a Buy at Maxim 12/20/21 Maxim Ayala Pharmaceuticals initiated with a Buy at Maxim AYLA Ayala Pharmaceuticals $1.09 / +0.04 (+3.81%) 05/16/22 Ayala Pharmaceuticals reports Q1 EPS (66c), consensus (68c)
Hot Stocks	Bragg Gaming announces Spin Games goes live in Connecticut » 08:04 07/05/22 07/05 08:04 07/05/22 08:04 BRAG Bragg Gaming $4.56 / + (+0.00%) , DKNG DraftKings $11.77 / +0.09 (+0.77%) Bragg Gaming (BRAG)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BRAG DKNG BRAG Bragg Gaming $4.56 / + (+0.00%) 06/30/22 Bragg Gaming extends distribution agreement with Kalamba Games 06/21/22 Oryx Gaming goes live with Jumpman Gaming 06/15/22 Bragg Gaming expands in Ontario though SkillOnNet collaboration 06/13/22 Bragg Gaming appoints Yaniv Sherman as CEO DKNG DraftKings $11.77 / +0.09 (+0.77%) 06/30/22 Nevada reports May statewide gaming win up 5.71% to $1.3B 06/16/22 New Jersey reports May gaming revenue up 15.1% to $430.6M 06/14/22 DraftKings, BetBlocker announce intercontinental collaboration 06/10/22 DraftKings, UFC extend strategic relationship for gamified NFTs BRAG DKNG BRAG Bragg Gaming $4.56 / + (+0.00%) 06/15/22 Maxim Bragg Gaming initiated with a Buy at Maxim 06/15/22 Maxim Bragg Gaming initiated with a Buy at Maxim 05/12/22 Canaccord Bragg Gaming price target lowered to C$15 from C$19 at Canaccord 03/11/22 Canaccord Bragg Gaming price target lowered to C$19 from C$21 at Canaccord DKNG DraftKings $11.77 / +0.09 (+0.77%) 06/29/22 Barclays Barclays initiates gaming sector, says Caesars best positioned 06/28/22 Barclays DraftKings initiated with an Equal Weight at Barclays 06/28/22 JMP Securities DraftKings initiated with an Outperform at JMP Securities 06/23/22 Morgan Stanley DraftKings assumed with an Overweight at Morgan Stanley BRAG DKNG BRAG Bragg Gaming $4.56 / + (+0.00%) 05/11/22 Bragg Gaming reiterates 2022 revenue view EUR 68M - EUR 72M 05/11/22 Bragg Gaming reports Q1 EPS (EUR 0.04) vs. (EUR 0.06) last year DKNG DraftKings $11.77 / +0.09 (+0.77%) 05/06/22 DraftKings raises 2022 revenue view $1.925B-$2.025B from $1.85B-$2B 05/06/22 DraftKings reports Q1 revenue $417M, consensus $412.01M 02/18/22 DraftKings raises 2022 revenue view $1.85B-$2B from $1.7B-$1.9B, consensus $1.9B 02/18/22 DraftKings reports Q4 revenue $473M, consensus $445.3M DKNG DKNG DraftKings $11.77 / +0.09 (+0.77%) 06/23/22 Fanatics in discussions to enter sports betting business, CNBC reports 05/16/22 DraftKings' Ontario license approved 6 weeks after market opens, IGB reports 05/03/22 Sportsbooks, tribes to have dueling ballot measures in California, WSJ reports 03/22/22 NY's top court says fantasy sports betting constitutional, Gambling.com says BRAG DKNG BRAG Bragg Gaming $4.56 / + (+0.00%) 07/01/22 Bet On It: Bally's enters sale-leaseback for Rhode Island casinos 06/24/22 Bet On It: Fanatics looks to enter sports betting space 06/17/22 Bet On It: Maryland governor calls for online sports betting timeline 06/03/22 Bet On It: Government wins as sportsbooks lose in New York sports betting market DKNG DraftKings $11.77 / +0.09 (+0.77%) 07/01/22 Bet On It: Bally's enters sale-leaseback for Rhode Island casinos 06/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/24/22 Bet On It: Fanatics looks to enter sports betting space 09/08/22 Consumer/Media/Entertainment Conference DKNG DKNG DraftKings $11.77 / +0.09 (+0.77%) 06/22/22 DraftKings put volume heavy and directionally bearish 06/08/22 DraftKings call volume above normal and directionally bullish 06/03/22 Unusually active option classes on open June 3rd 05/24/22 Unusually active option classes on open May 24th
Hot Stocks	OneSpan appoints Michael Lillie as Chief Information Officer » 08:04 07/05/22 07/05 08:04 07/05/22 08:04 OSPN OneSpan $12.15 / +0.28 (+2.36%) OneSpan that Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings OSPN OneSpan $12.15 / +0.28 (+2.36%) 06/13/22 OneSpan announces Lara Mataac as General Counsel and Chief Compliance Officer 05/23/22 OneSpan announces Michael Klieman as chief product officer 03/16/22 OneSpan appoints Eric Hanson as chief marketing officer 02/08/22 OneSpan, Smart Communications partner to expand e-signature integration OSPN OneSpan $12.15 / +0.28 (+2.36%) 02/23/22 DA Davidson OneSpan price target lowered to $23 from $32 at DA Davidson OSPN OneSpan $12.15 / +0.28 (+2.36%) 05/03/22 OneSpan sees FY22 revenue to meet or exceed full year 2021 revenue 05/03/22 OneSpan reports Q1 adjusted EPS (1c), consensus (5c) 02/22/22 OneSpan sees FY22 revenue meeting or exceeding FY21 revenue 02/22/22 OneSpan reports Q4 adjusted EPS (24c), consensus (8c)
Recommendations	Franchise Group 'no worse off' than before without Kohl's, says DA Davidson » 08:03 07/05/22 07/05 08:03 07/05/22 08:03 FRG Franchise Group $32.48 / -2.57 (-7.33%) DA Davidson analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly FRG Franchise Group $32.48 / -2.57 (-7.33%) 07/01/22 Franchise Group says negotiations to acquire Kohl's have been terminated 06/21/22 Franchise Group announces sale of W.S. Badcock corporation distribution centers 06/07/22 Franchise Group to contribute $1B to Kohl's transaction upon definitive deal 06/06/22 Kohl's confirms 3-week exclusive talks with Franchise Group at $60 per share FRG Franchise Group $32.48 / -2.57 (-7.33%) 06:53 Today Baird Kohl's price target lowered to $42 from $53 at Baird 05/06/22 B. Riley Franchise Group price target lowered to $63 from $65 at B. Riley 01/03/22 B. Riley iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022 12/08/21 Barrington Franchise Group price target raised to $65 from $58 at Barrington FRG Franchise Group $32.48 / -2.57 (-7.33%) 05/05/22 Franchise Group backs FY22 revenue view $4.45B, consensus $4.42B 05/05/22 Franchise Group reports Q1 adjusted EPS $1.29, consensus $1.09 FRG Franchise Group $32.48 / -2.57 (-7.33%) 07/01/22 Kohl's looking to sell some real estate, board chair tells CNBC 07/01/22 Kohl's terminates buyout talks with Franchise Group, CNBC reports 06/22/22 Franchise Group considers lowering Kohl's bid nearer to $50 per share, CNBC says 06/22/22 Franchise Group in discussions to maintain Kohl's executives, Reuters says FRG Franchise Group $32.48 / -2.57 (-7.33%) 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning 07/01/22 Fly Intel: Pre-market Movers 06/22/22 What You Missed On Wall Street On Wednesday
Hot Stocks	Chinook Therapeutics' BION-1301 receives orphan drug designation in Europe » 08:02 07/05/22 07/05 08:02 07/05/22 08:02 KDNY Chinook Therapeutics $17.51 / +0.06 (+0.34%) Chinook Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly KDNY Chinook Therapeutics $17.51 / +0.06 (+0.34%) 06/07/22 Point72 Asset Management reports 5.1% passive stake in Chinook Therapeutics 05/20/22 Chinook announces two oral presentations on atrasentan clinical program 04/12/22 Chinook Therapeutics announces initiation of Phase 1 trial of CHK-336 04/05/22 Chinook, IgA Nephropathy Foundation, Komodo Health announce collaboration KDNY Chinook Therapeutics $17.51 / +0.06 (+0.34%) 06/27/22 Stifel Chinook Therapeutics initiated with a Buy at Stifel 02/01/22 H.C. Wainwright H.C. Wainwright sees no negative read-through from Chinook CMO departure KDNY Chinook Therapeutics $17.51 / +0.06 (+0.34%) 05/12/22 Chinook Therapeutics reports Q1 EPS (54c), consensus (67c) 03/17/22 Chinook Therapeutics reports Q4 EPS 14c, consensus (68c) 25 May 10 Nov KDNY Chinook Therapeutics $17.51 / +0.06 (+0.34%) 05/25/22 Fly Intel: Pre-market Movers 05/24/22 Fly Intel: After-Hours Movers

Events

Earnings calls, analyst events, roadshows and more

ALNA
Today at 09:00

Allena Pharmaceuticals, Inc. Firm Sponsored Meetings
Today at 10:00

Factory Orders M/M: May 2022 Government Event
PRPO
Today at 10:00

Precipio, Inc. Firm Sponsored Meetings
Today at 11:00

4-Week Bill Announcement Government Event
Today at 11:00

8-Week Bill Announcement Government Event
MIST
Today at 11:00

Milestone Pharmaceuticals Inc. Firm Sponsored Meetings
Today at 11:30

3-Month Bill Auction Government Event
Today at 11:30

6-Month Bill Auction Government Event
Tomorrow at 00:00

17th International Congress on Neuromuscular Diseases Conferences

Brussels
Tomorrow at 00:00

Annual Meeting 2022 of the BRS Conferences

Manchester Metropolitan University, Manchester

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

ProQR Therapeutics reports Q1 EPS (20c), consensus (25c)

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access